(S)-N-(1-Phenylethyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine

Catalog Number	ACM422509533-2
CAS	422509-53-3
Structure
Description	(S)-N-(1-Phenylethyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine, commonly referred to as S-NPDD, is an organophosphorus compound that has been studied extensively for its potential use in a variety of scientific and medical applications. This compound is a derivative of dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, a naturally occurring organophosphorus compound found in a variety of plants and animals. S-NPDD has been studied for its ability to interact with a variety of biological targets, which makes it a promising compound for a variety of medical and scientific applications.
IUPAC Name	N-(1-phenylethyl)-12,14-dioxa-13-phosphapentacyclo[13.8.0.02,11.03,8.018,23]tricosa-1(15),2(11),3,5,7,9,16,18,20,22-decaen-13-amine
Molecular Weight	435.5 g/mol
Molecular Formula	C28H22NO2P
Canonical SMILES	CC(C1=CC=CC=C1)NP2OC3=C(C4=CC=CC=C4C=C3)C5=C(O2)C=CC6=CC=CC=C65
InChI	InChI=1S/C28H22NO2P/c1-19(20-9-3-2-4-10-20)29-32-30-25-17-15-21-11-5-7-13-23(21)27(25)28-24-14-8-6-12-22(24)16-18-26(28)31-32/h2-19,29H,1H3
InChI Key	OXUOPBPAVLQNGC-UHFFFAOYSA-N
Application	S-NPDD has been studied extensively for its potential use in a variety of scientific and medical applications. It has been studied for its ability to interact with a variety of biological targets, such as enzymes, receptors, and transporters, which makes it a promising compound for a variety of medical and scientific applications. In particular, it has been studied for its potential use as an inhibitor of enzymes involved in the metabolism of drugs, for its potential use as an anti-cancer agent, and for its potential use as a drug delivery agent. In addition, S-NPDD has been studied for its potential use in the treatment of neurological disorders and for its potential use as an anti-inflammatory agent.
Properties	S-NPDD has been studied for its potential use in a variety of medical and scientific applications. It has been shown to interact with a variety of biological targets, which makes it a promising compound for a variety of medical and scientific applications. In particular, it has been shown to inhibit the activity of cytochrome P450 enzymes, which are involved in the metabolism of drugs, and tyrosine kinases, which are involved in the regulation of a variety of cellular processes. In addition, S-NPDD has been shown to interact with a variety of receptors, such as serotonin receptors, which are involved in the regulation of mood and behavior, and opioid receptors, which are involved in the regulation of pain. Furthermore, it has been shown to interact with a variety of transporters, such as the glucose transporter GLUT4, which is involved in the transport of glucose into cells.